Page 30 - EASL POSTGRADUATE COURSE
P. 30
References
[1] Morling JR, Fallowfield JA, Guha IN, et al. Using non-invasive biomarkers to identify hepatic
fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study. J Hepatol
2014;60:384-391.
[2] Neuschwander-Tetri BA, Clark JM, Bass NM, et al. Clinical, laboratory and histological
associations in adults with nonalcoholic fatty liver disease. Hepatology 2010;52:913-924.
[3] Angulo P, Keach JC, Batts KP, et al. Independent predictors of liver fibrosis in patients with
nonalcoholic steatohepatitis. Hepatology 1999;30:1356-1362.
[4] Harrison SA, Oliver D, Arnold HL, et al. Development and validation of a simple NAFLD clinical
scoring system for identifying patients without advanced disease. Gut 2008;57:1441-1447.
[5] Adams LA, George J, Bugianesi E, et al. Complex non-invasive fibrosis models are more accurate
than simple models in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2011;26:1536-
1543.
[6] Shah AG, Lydecker A, Murray K, et al. Comparison of noninvasive markers of fibrosis in patients
with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009;7:1104-1112.
[7] Angulo P, Bugianesi E, Bjornsson ES, et al. Simple noninvasive systems predict long-term
outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 2013;145:782-789
e784.
[8] Sebastiani G, Castera L, Halfon P, et al. The impact of liver disease aetiology and the stages of
hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of
2411 cases. Aliment Pharmacol Ther 2011;34:1202-1216.
[9] Poynard T, Lassailly G, Diaz E, et al. Performance of biomarkers FibroTest, ActiTest, SteatoTest,
and NashTest in patients with severe obesity: meta analysis of individual patient data. PLoS One
2012;7:e30325.
[10] Castera L, Vilgrain V, Angulo P. Noninvasive evaluation of NAFLD. Nat Rev Gastroenterol
Hepatol 2013;10:666-675.
[11] Kwok R, Tse YK, Wong GL, et al. Systematic review with meta-analysis: non-invasive assessment
of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18
fragments. Aliment Pharmacol Ther 2014;39:254-269.
[12] Petta S,Vanni E, Bugianesi E, et al. The combination of liver stiffness measurement and NAFLD
fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with
nonalcoholic fatty liver disease. Liver Int 2014; doi: 10.1111/liv.12584.
[13] Wong VW, Vergniol J, Wong GL, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness
measurement in nonalcoholic fatty liver disease. Hepatology 2010;51:454-462.
[14] Palmeri ML,Wang MH, Rouze NC, et al. Noninvasive evaluation of hepatic fibrosis using acoustic
radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. J Hepatol
2011;55:666-672.
[15] Loomba R, Wolfson T, Ang B, et al. Magnetic resonance elastography predicts advanced fibrosis
in patients with nonalcoholic fatty liver disease: a prospective study. Hepatology 2014;60:1920-
1928.
[16] Musso G, Gambino R, Cassader M, et al. Meta-analysis: natural history of non-alcoholic fatty
liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann
Med 2011;43:617-649.
[17] Naveau S, Lamouri K, Pourcher G, et al. The diagnostic accuracy of transient elastography for
the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD. Obes Surg
2014;24:1693-1701.
30 Postgraduate Course Syllabus • Metabolic Liver Disease
[1] Morling JR, Fallowfield JA, Guha IN, et al. Using non-invasive biomarkers to identify hepatic
fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study. J Hepatol
2014;60:384-391.
[2] Neuschwander-Tetri BA, Clark JM, Bass NM, et al. Clinical, laboratory and histological
associations in adults with nonalcoholic fatty liver disease. Hepatology 2010;52:913-924.
[3] Angulo P, Keach JC, Batts KP, et al. Independent predictors of liver fibrosis in patients with
nonalcoholic steatohepatitis. Hepatology 1999;30:1356-1362.
[4] Harrison SA, Oliver D, Arnold HL, et al. Development and validation of a simple NAFLD clinical
scoring system for identifying patients without advanced disease. Gut 2008;57:1441-1447.
[5] Adams LA, George J, Bugianesi E, et al. Complex non-invasive fibrosis models are more accurate
than simple models in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2011;26:1536-
1543.
[6] Shah AG, Lydecker A, Murray K, et al. Comparison of noninvasive markers of fibrosis in patients
with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009;7:1104-1112.
[7] Angulo P, Bugianesi E, Bjornsson ES, et al. Simple noninvasive systems predict long-term
outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 2013;145:782-789
e784.
[8] Sebastiani G, Castera L, Halfon P, et al. The impact of liver disease aetiology and the stages of
hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of
2411 cases. Aliment Pharmacol Ther 2011;34:1202-1216.
[9] Poynard T, Lassailly G, Diaz E, et al. Performance of biomarkers FibroTest, ActiTest, SteatoTest,
and NashTest in patients with severe obesity: meta analysis of individual patient data. PLoS One
2012;7:e30325.
[10] Castera L, Vilgrain V, Angulo P. Noninvasive evaluation of NAFLD. Nat Rev Gastroenterol
Hepatol 2013;10:666-675.
[11] Kwok R, Tse YK, Wong GL, et al. Systematic review with meta-analysis: non-invasive assessment
of non-alcoholic fatty liver disease--the role of transient elastography and plasma cytokeratin-18
fragments. Aliment Pharmacol Ther 2014;39:254-269.
[12] Petta S,Vanni E, Bugianesi E, et al. The combination of liver stiffness measurement and NAFLD
fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with
nonalcoholic fatty liver disease. Liver Int 2014; doi: 10.1111/liv.12584.
[13] Wong VW, Vergniol J, Wong GL, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness
measurement in nonalcoholic fatty liver disease. Hepatology 2010;51:454-462.
[14] Palmeri ML,Wang MH, Rouze NC, et al. Noninvasive evaluation of hepatic fibrosis using acoustic
radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. J Hepatol
2011;55:666-672.
[15] Loomba R, Wolfson T, Ang B, et al. Magnetic resonance elastography predicts advanced fibrosis
in patients with nonalcoholic fatty liver disease: a prospective study. Hepatology 2014;60:1920-
1928.
[16] Musso G, Gambino R, Cassader M, et al. Meta-analysis: natural history of non-alcoholic fatty
liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann
Med 2011;43:617-649.
[17] Naveau S, Lamouri K, Pourcher G, et al. The diagnostic accuracy of transient elastography for
the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD. Obes Surg
2014;24:1693-1701.
30 Postgraduate Course Syllabus • Metabolic Liver Disease
